The role of positron emission tomography in the management of pancreatic cancer.
about
Strategies for early detection of resectable pancreatic cancerUtility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancerDetection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CTPrognostic significance of SUVmax and serum carbohydrate antigen 19-9 in pancreatic cancer.Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy.Preliminary evaluation of 1'-[(18)F]fluoroethyl-β-D-lactose ([(18)F]FEL) for detection of pancreatic cancer in nude mouse orthotopic xenografts.Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancerMultimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature.Sister Mary Joseph's nodule as a first sign of pancreatic cancer.Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer.Pancreatic cystic neoplasms: a review of preoperative diagnosis and management.Enzyme inhibition of dopamine metabolism alters 6-[18F]FDOPA uptake in orthotopic pancreatic adenocarcinoma.Imaging of pancreatic ductal adenocarcinoma: State of the art.FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancerFDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer.Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.Nanoprobes for hybrid SPECT/MR molecular imaging.Metabolic signatures of malignant and non-malignant mass-forming lesions in the periampulla and pancreas in FDG PET/CT scan: an atlas with pathologic correlation.Optimization of precursor synthesis, formulation and stability of 1'-[18F]fluoroethyl-β-D-lactose ([18F]FEL) for preclinical studies in detection of pancreatic cancer.Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer.Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study.The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.Absence of a Periampullary Mass on Cross-sectional Imaging Delays Diagnosis and Time to Pancreatoduodenectomy But Does Not Impair Outcome.Pankreaskarzinom: Aktuelle Standards der chirurgischen Therapie
P2860
Q24564006-580671ED-8D92-4D82-95ED-E43F554199ECQ26827392-88A8D386-9CF0-4336-8E0A-E729BEB7FAA5Q30945833-21A9635F-4CCC-4F2F-8226-5E6D89684B4AQ33626863-EADDBA66-A5BD-4583-B9FD-5012B24FCF1FQ34072096-49A0223F-8D2E-48AF-9155-87AFC80EE4ACQ34315514-013284B9-4AFD-4E14-B717-7EFB5A8F8D05Q34392691-4C75B35D-D7F1-4753-B67F-BFFD7C09A6F4Q34487208-593EA36D-FA36-4EB5-B312-264A15ABD261Q36288743-16FA2DE8-7544-47BE-ACBD-C5B2B368C3D2Q36450473-3D9BCED9-26C4-44C0-9B5F-BB47233B6771Q36494203-9E325AE5-16DA-445B-9B27-BA4C97B3C1DEQ36681492-E3703755-5042-46D8-844F-90D6F6FBCE90Q36744866-664AC912-5801-47AE-8046-EB0AD5C88046Q36832133-BD10C6AE-C57B-4E61-A2AB-C924A0C36956Q36919818-47B56709-BE2A-4BE7-A2C2-004EA8C6FAB2Q37169721-963278E0-4E7F-45F9-87FE-1281E9C836C3Q37652687-C7A87D83-D525-4600-B6D0-E6EF343774C0Q38004855-FDEA90DC-DB37-41CD-856C-E32368BB83D1Q38013146-48218A01-BCAE-4381-92DC-8D01DCD1B23FQ38258220-DCC85B3D-5417-4A47-8E0F-23D4BD0B7B89Q38406264-263BB3F6-98A1-42CE-B381-B52C29D82539Q39429337-710E1E1B-6D70-4872-BC72-F0BC2A59717BQ42385426-5E6FD6D5-0F42-4E10-8072-2D95C68144C8Q46644415-1BE57D2E-4A11-4936-8730-F28A4AC2ED25Q46876969-069510D2-93DD-4169-A04B-1A4986DBF125Q52984302-AEEF9316-4A46-4F1F-8AE6-FC7F932B737AQ57767497-1E0E8439-41D0-4379-847A-CAD2992917B3
P2860
The role of positron emission tomography in the management of pancreatic cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The role of positron emission tomography in the management of pancreatic cancer.
@ast
The role of positron emission tomography in the management of pancreatic cancer.
@en
type
label
The role of positron emission tomography in the management of pancreatic cancer.
@ast
The role of positron emission tomography in the management of pancreatic cancer.
@en
prefLabel
The role of positron emission tomography in the management of pancreatic cancer.
@ast
The role of positron emission tomography in the management of pancreatic cancer.
@en
P2093
P1476
The role of positron emission tomography in the management of pancreatic cancer.
@en
P2093
Ashley M Groves
Farrokh Pakzad
Peter J Ell
P304
P356
10.1053/J.SEMNUCLMED.2006.03.005
P577
2006-07-01T00:00:00Z